A detailed history of Voya Investment Management LLC transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 33,061 shares of MCRB stock, worth $23,803. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,061
Previous 40,532 18.43%
Holding current value
$23,803
Previous $56,000 55.36%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.75 - $1.56 $5,603 - $11,654
-7,471 Reduced 18.43%
33,061 $25,000
Q3 2023

Nov 14, 2023

BUY
$2.33 - $5.07 $4,054 - $8,821
1,740 Added 4.49%
40,532 $96,000
Q2 2023

Aug 14, 2023

BUY
$4.67 - $6.55 $52,318 - $73,379
11,203 Added 40.61%
38,792 $185,000
Q4 2021

Feb 14, 2022

BUY
$6.02 - $11.43 $1,523 - $2,891
253 Added 0.93%
27,589 $230,000
Q2 2021

Aug 16, 2021

BUY
$18.46 - $24.36 $61,785 - $81,532
3,347 Added 13.95%
27,336 $652,000
Q1 2021

May 17, 2021

BUY
$17.66 - $28.92 $8,423 - $13,794
477 Added 2.03%
23,989 $494,000
Q4 2020

Feb 16, 2021

BUY
$23.25 - $37.73 $129,851 - $210,722
5,585 Added 31.15%
23,512 $576,000
Q3 2020

Nov 16, 2020

BUY
$3.74 - $28.74 $8,803 - $67,653
2,354 Added 15.12%
17,927 $508,000
Q2 2020

Aug 14, 2020

SELL
$3.04 - $6.2 $11,266 - $22,977
-3,706 Reduced 19.22%
15,573 $74,000
Q4 2019

Feb 14, 2020

BUY
$2.99 - $4.42 $16,770 - $24,791
5,609 Added 41.03%
19,279 $67,000
Q3 2019

Nov 14, 2019

BUY
$2.29 - $4.16 $8,140 - $14,788
3,555 Added 35.15%
13,670 $55,000
Q3 2017

Nov 14, 2017

BUY
$12.81 - $16.85 $129,573 - $170,437
10,115
10,115 $162,000

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $89.3M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.